StockNews.com cut shares of Owens & Minor (NYSE:OMI – Free Report) from a buy rating to a hold rating in a research report released on Friday morning.
OMI has been the subject of a number of other reports. Barclays lowered their price target on shares of Owens & Minor from $23.00 to $18.00 and set an equal weight rating for the company in a report on Monday, August 5th. Bank of America lowered their price target on shares of Owens & Minor from $18.00 to $16.00 and set an underperform rating for the company in a report on Tuesday, June 25th. Citigroup raised shares of Owens & Minor from a neutral rating to a buy rating and decreased their price objective for the stock from $24.00 to $19.00 in a report on Friday, July 19th. Finally, Robert W. Baird decreased their price objective on shares of Owens & Minor from $20.00 to $19.00 and set a neutral rating for the company in a report on Tuesday, July 16th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, Owens & Minor currently has a consensus rating of Hold and a consensus price target of $20.14.
Get Our Latest Stock Analysis on Owens & Minor
Owens & Minor Price Performance
Owens & Minor (NYSE:OMI – Get Free Report) last released its quarterly earnings results on Friday, August 2nd. The company reported $0.36 earnings per share for the quarter, beating analysts’ consensus estimates of $0.33 by $0.03. The business had revenue of $2.67 billion during the quarter, compared to analyst estimates of $2.65 billion. Owens & Minor had a negative net margin of 0.37% and a positive return on equity of 12.97%. The business’s revenue was up 4.2% on a year-over-year basis. During the same period last year, the business earned $0.18 EPS. As a group, analysts predict that Owens & Minor will post 1.54 EPS for the current year.
Insiders Place Their Bets
In other news, CFO Alexander J. Bruni sold 10,568 shares of the firm’s stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $17.76, for a total value of $187,687.68. Following the transaction, the chief financial officer now directly owns 49,950 shares in the company, valued at approximately $887,112. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other news, Director Mark A. Beck sold 9,344 shares of the firm’s stock in a transaction dated Wednesday, June 5th. The shares were sold at an average price of $17.25, for a total value of $161,184.00. Following the transaction, the director now directly owns 11,154 shares in the company, valued at approximately $192,406.50. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Alexander J. Bruni sold 10,568 shares of the firm’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $17.76, for a total transaction of $187,687.68. Following the completion of the transaction, the chief financial officer now owns 49,950 shares in the company, valued at $887,112. The disclosure for this sale can be found here. Insiders sold a total of 31,923 shares of company stock valued at $562,711 in the last ninety days. Corporate insiders own 3.59% of the company’s stock.
Institutional Inflows and Outflows
Large investors have recently modified their holdings of the business. Riverview Trust Co bought a new stake in Owens & Minor in the 1st quarter valued at about $25,000. Quest Partners LLC bought a new stake in Owens & Minor in the 4th quarter valued at about $41,000. Hexagon Capital Partners LLC lifted its position in Owens & Minor by 1,240.2% in the 1st quarter. Hexagon Capital Partners LLC now owns 1,568 shares of the company’s stock valued at $43,000 after purchasing an additional 1,451 shares during the last quarter. Innealta Capital LLC bought a new stake in Owens & Minor in the 2nd quarter valued at about $43,000. Finally, DekaBank Deutsche Girozentrale lifted its position in Owens & Minor by 76.6% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 3,126 shares of the company’s stock valued at $43,000 after purchasing an additional 1,356 shares during the last quarter. 98.04% of the stock is currently owned by institutional investors.
About Owens & Minor
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.
Further Reading
- Five stocks we like better than Owens & Minor
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- How to Invest in Silver: A Beginner’s Guide
- Retail Stocks Investing, Explained
- Monday.com’s Stock Results Will Brighten Any Investor’s Week
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- 3 Must-Watch Stocks After a Bullish Goldman Sachs Recommendation
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.